Plinest® Wins Best Injectable for Mature Skin at Menopause in Practice Awards
Plinest® has been recognised as the Best Injectable for Mature Skin at the Menopause in Practice Awards for the second year in a row, reinforcing its position as a leading option for supporting skin quality in patients experiencing hormonally-driven ageing.
The award highlights growing recognition of regenerative approaches within menopause-focused care, where changes in oestrogen levels can contribute to reduced collagen production, diminished skin elasticity, and increased dryness. Treatments that support dermal function and long-term tissue health are becoming increasingly relevant in this patient group.
Plinest®, developed using Polynucleotides HPT®, is designed to support fibroblast activity, promote collagen synthesis and improve hydration, contributing to enhanced skin quality over time. Its regenerative mechanism makes it particularly suited to mature skin, where structural support and biological function are key considerations in treatment planning.
This latest recognition builds on a strong track record of industry accolades. At the Menopause in Practice Awards 2025, Plinest® also received Best Menopause Regenerative Product and Best Injectable Product for Mature Skin, underlining its relevance within this patient group.
It has also achieved success at the Aesthetics Awards 2025, where it was named Best Injectable Product, having previously won Best New Product at the Aesthetics Awards 2024.
At DermaFocus, we are proud to support the continued clinical success of Plinest® across the UK and Ireland, as part of our commitment to advancing evidence-based regenerative aesthetics.
To find out more about Plinest®and book training visit our RISE education platform here.
Recent Comments